ODAC 30% Off Registration, Use Code: JDD30
Skip to main content
Atopic DermatitisFeatured ArticlesJDD Highlights

December Issue Article Highlight: Bacteriophages: An Alternative to Combat Antibiotic Resistance?

By December 6, 2022No Comments

Dermatology News

JDD Highlights

Please take some time to review the December 2022 issue of the JDD. As a reminder, last month’s articles are still available to JDD subscribers in our Archive Library.

Read the Article

Bacteriophages: An Alternative to Combat Antibiotic Resistance?

by Monik Gupta BAa, Madison J. Anzelc MDa, Samuel A. Stetkevich MDa, Craig G. Burkhart MPH MDa,b

ABSTRACT

Background: Antibiotic resistance has become one of the largest pitfalls of modern medicine, and this has fueled the search for a safe and effective alternative. Of these alternatives, bacteriophage (phage) therapy has emerged as a potential option since it is capable of destroying pathogenic bacteria, without disrupting commensal bacterial populations. Although numerous studies have shown its efficacy in various conditions such as dysentery, sepsis, and meningitis, very little research has focused on its prospective usage to treat dermatological conditions. This review discusses the emerging phage therapy studies surrounding infections caused by Cutibacterium acnes (C. acnes), Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Klebsiella pneumoniae (K. pneumoniae). Phage therapy shows major potential for future usage in the field of dermatology, yet further research must be performed to assure safety and efficacy in humans.

J Drugs Dermatol. 2022;21(12):1311-1315. doi:10.36849/JDD.6638

Other Articles

You May Also Like

Journal of Drugs in Dermatology JDD featuring video abstracts on Celebrating National Healthy Skin Month: Essential Vault Reads From JDD

Celebrating National Healthy Skin Month: Essential Vault Reads From JDD

| Featured Articles, Latest News, Skincare | No Comments
Explore high-impact research on barrier protection, photoprotection, and targeted skincare strategies to optimize lifelong skin health November is National Healthy Skin Month, making it the perfect opportunity to pull foundational…
Journal of Drugs in Dermatology JDD featuring Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials

Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials

| Featured Articles, Latest News | No Comments
Targeting BTK in Cutaneous Lupus: What New Clinical Trial Data Reveals for Dermatologists Have you explored the newest systematic review from the Journal of Drugs in Dermatology examining the potential of…
Journal of Drugs in Dermatology JDD featuring Tackling Female Hair Loss: Gentle Topicals vs. In-Office Mesotherapy

Tackling Female Hair Loss: Gentle Topicals vs. In-Office Mesotherapy

| Alopecia, Dyspigmentation, Featured Articles, Hair, Latest News, Women | No Comments
Weighing efficacy and risks across non-surgical hair restoration methods Hair restoration continues to dominate clinical inquiries, representing some of JDD's most read topics that we are bringing back out of…

Leave a Reply